Author:
Ahring Philip K.,Olsen Jeppe A.,Nielsen Elsebet Ø.,Peters Dan,Pedersen Martin H.F.,Rohde Line A.,Kastrup Jette S.,Shahsavar Azadeh,Indurthi Dinesh C.,Chebib Mary,Gajhede Michael,Balle Thomas
Funder
IMK Almene Fond
Australian National Health and Medical Research Council
Danish Agency for Science, Technology and Innovation
University of Copenhagen
Subject
Cellular and Molecular Neuroscience,Pharmacology
Reference36 articles.
1. Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4β2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealed;Absalom;J. Biol. Chem.,2013
2. A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD;Bain;Neuropsychopharmacology,2013
3. Nicotinic acetylcholine receptors: an overview on drug discovery;D'Hoedt;Expert Opin. Ther. Targets,2009
4. [125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors;Davila-Garcia;J. Pharmacol. Exp. Ther.,1997
5. Synthesis and structure-activity relationships of 3,8-diazabicyclo[4.2.0]octane ligands, potent nicotinic acetylcholine receptor agonists;Frost;J. Med. Chem.,2006
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献